Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05904886
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-05-23
Brief Title:
A Study Evaluating Atezolizumab and Bevacizumab With or Without Tiragolumab in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma IMbrave152
Sponsor:
Organization:
Hoffmann-La Roche